Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Dialysis has kept patients alive for decades, but it's far from perfect — and researchers are racing to change that. From portable devices to implantable artificial kidneys, the next generation of kidney replacement therapy aims to be more continuous, physiologic, and patient-friendly. Germany is also rolling out new financial incentives to boost home dialysis adoption, which currently sits at a low 7%.
Dialysis has been a lifeline for patients with kidney failure for 60+ years, but it still falls well short of replicating what a healthy kidney does. Younger dialysis patients face mortality rates 20–50 times higher than their healthy peers, largely because conventional hemodialysis can't fully clear harmful uremic toxins — especially protein-bound ones linked to cardiovascular disease. That's driving a wave of innovation aimed at making dialysis more continuous, physiologic, and less disruptive to daily life.
Researchers are developing portable dialysis systems, miniaturized devices, and even implantable artificial kidneys. Novel membranes made from polymeric or inorganic materials could improve toxin clearance, and bioartificial kidneys — combining synthetic membranes with living kidney cells — are on the horizon. The goal: treatment that fits around patients' lives, not the other way around.
By the Numbers
Why it matters: As the dialysis population ages and grows more complex, the field urgently needs therapies that reduce cardiovascular risk, lower treatment burden, and support patient independence — both clinically and at the policy level.
